Publication | Open Access

Synthesis and biological evaluation of N-aryl salicylamides with a hydroxamic acid moiety at 5-position as novel HDAC–EGFR dual inhibitors

Molecular PharmacologyMedicinal ChemistryBiochemistryHydroxamic Acid MoietyMedicineNatural SciencesN-aryl SalicylamidesRational Drug DesignPharmacotherapyBiological EvaluationAnti-cancer AgentDrug DevelopmentPharmacologyPharmaceutical ChemistryDrug Discovery